Full Press Release Details
annualreportandacco.
AUTL
annualreportandacco
Key Takeaway: annualreportandacco
Price reaction · baseline $2.48 (2023-07-06 close) · hit after-hours · clean, no other AUTL news in the window
day 0 close
0%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
11.6%
average across 2 past catalysts
Cash runway
~24 mo
Low dilution risk
Lead asset
Obecabtagene autoleucel
Phase 2 · Lupus Nephritis